Who is sponsoring NCT03695731?

NCT03695731 is sponsored by Doctor Giacomo Gastaldi.

What drugs are being tested in NCT03695731?

Interventions in NCT03695731: cold induced activation of brown adipose tissue.

What condition does NCT03695731 study?

NCT03695731 studies Diabetes Mellitus, Type 1.

Is NCT03695731 still recruiting?

NCT03695731 is currently status unknown. Last updated 9 May 2019.

Last reviewed 2019-05-09 · How we verify

NCT03695731: DIA-BAT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Influence of Diabetic Neuropathy on Activation of Brown Adipose Tissue

Status unknown NA Last updated 9 May 2019

What this trial tests

NA trial testing cold induced activation of brown adipose tissue in Diabetes Mellitus, Type 1 in 24 participants. Status unknown.

Timeline

15 October 2018

Primary endpoint
15 October 2019

15 October 2019

Quick facts

Lead sponsor	Doctor Giacomo Gastaldi
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	basic science
Enrollment	24
Start date	15 October 2018
Primary completion	15 October 2019
Estimated completion	15 October 2019
Sites	1 location across Switzerland

Drugs / interventions tested

cold induced activation of brown adipose tissue

Conditions studied

Diabetes Mellitus, Type 1 — all drugs for Diabetes Mellitus, Type 1 →

Sponsor

Doctor Giacomo Gastaldi

Who can join

18 and older, any sex, with Diabetes Mellitus, Type 1. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Influence of diabetic neuropathy on cold induced brown adipose tissue in type 1 diabetic patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Diabetes Mellitus, Type 1

Currently open trials in the same condition.

NCT07325461 — Feasibility Study of Extended Wear Insulin Infusion Set Options During Home Use in People With Type 1 Diabetes · NA · recruiting
NCT07305805 — A Research Study of a New Medicine NNC0363-1063 in Participants With Type 1 Diabetes · Phase 1 · recruiting
NCT06282055 — Trajectories in Insulin Sensitivity Across MEnstrual cycleS in Women With Type 1 Diabetes · recruiting
NCT06325202 — Closed Loop and Education for Hypoglycemia Awareness Restoration · NA · recruiting
NCT07160816 — A Research Study to See How Insulin Icodec Helps People With Type 1 Diabetes Control Their Blood Sugar · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03695731 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Doctor Giacomo Gastaldi
Last refreshed: 9 May 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03695731.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing